These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10337717)

  • 21. Recent advances in chemoprevention of cancer.
    Hong WK; Sporn MB
    Science; 1997 Nov; 278(5340):1073-7. PubMed ID: 9353183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antioxidant activity and other mechanisms of thiols involved in chemoprevention of mutation and cancer.
    De Flora S; Izzotti A; D'Agostini F; Cesarone CF
    Am J Med; 1991 Sep; 91(3C):122S-130S. PubMed ID: 1928203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Micronutrients as chemopreventive agents.
    Reddy BS
    IARC Sci Publ; 1996; (139):221-35. PubMed ID: 8923033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic and epigenetic cancer chemoprevention on molecular targets during multistage carcinogenesis.
    Kim HS; Kacew S; Lee BM
    Arch Toxicol; 2016 Oct; 90(10):2389-404. PubMed ID: 27538406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tea and cancer chemoprevention: a comprehensive review.
    Shukla Y
    Asian Pac J Cancer Prev; 2007; 8(2):155-66. PubMed ID: 17696725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chemoprevention of cancer. Prevention of cancer in groups with increased risk].
    Sanner T; Dybing E
    Tidsskr Nor Laegeforen; 1996 Aug; 116(19):2329-33. PubMed ID: 8804210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoprevention by isothiocyanates and their underlying molecular signaling mechanisms.
    Keum YS; Jeong WS; Kong AN
    Mutat Res; 2004 Nov; 555(1-2):191-202. PubMed ID: 15476860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemoprevention: from research to clinical oncology.
    Veronesi U; Bonanni B
    Eur J Cancer; 2005 Sep; 41(13):1833-41. PubMed ID: 16061373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: the Seventh DeWitt S. Goodman Lecture.
    Conney AH
    Cancer Res; 2003 Nov; 63(21):7005-31. PubMed ID: 14612489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Special issue: Mechanistic approaches to chemoprevention of mutation and cancer. Dedicated to Giorgio Bronzetti (1939-2005).
    Mutat Res; 2005 Dec; 591(1-2):1-310. PubMed ID: 16977692
    [No Abstract]   [Full Text] [Related]  

  • 32. Cancer chemoprevention with garlic and its constituents.
    Shukla Y; Kalra N
    Cancer Lett; 2007 Mar; 247(2):167-81. PubMed ID: 16793203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Data evaluation as a contribution to cancer prevention.
    Stewart BW
    IARC Sci Publ; 1996; (139):303-12. PubMed ID: 8923040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways.
    Ramos S
    Mol Nutr Food Res; 2008 May; 52(5):507-26. PubMed ID: 18435439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perspectives in cancer chemoprevention.
    Stoner GD; Morse MA; Kelloff GJ
    Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):945-54. PubMed ID: 9255586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multistage carcinogenesis process as molecular targets in cancer chemoprevention by epicatechin-3-gallate.
    Pan MH; Chiou YS; Wang YJ; Ho CT; Lin JK
    Food Funct; 2011 Feb; 2(2):101-10. PubMed ID: 21779554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer chemoprevention: progress and promise.
    Kelloff GJ; Sigman CC; Greenwald P
    Eur J Cancer; 1999 Dec; 35(13):1755-62. PubMed ID: 10673988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas.
    Kensler TW; Egner PA; Wang JB; Zhu YR; Zhang BC; Lu PX; Chen JG; Qian GS; Kuang SY; Jackson PE; Gange SJ; Jacobson LP; Muñoz A; Groopman JD
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S310-8. PubMed ID: 15508099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surrogate end-point biomarkers in chemopreventive drug development.
    Kelloff GJ; Sigman CC; Hawk ET; Johnson KM; Crowell JA; Guyton KZ
    IARC Sci Publ; 2001; 154():13-26. PubMed ID: 11220652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stage matters: choosing relevant model systems to address hypotheses in diet and cancer chemoprevention research.
    Fenton JI; Hord NG
    Carcinogenesis; 2006 May; 27(5):893-902. PubMed ID: 16474168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.